95 related articles for article (PubMed ID: 23859045)
1. Evaluation of hydro-alcoholic extract of Eclipta alba for its multidrug resistance reversal potential: an in vitro study.
Chaudhary H; Jena PK; Seshadri S
Nutr Cancer; 2013; 65(5):775-80. PubMed ID: 23859045
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of hydro-alcoholic extract of Eclipta alba for its anticancer potential: an in vitro study.
Chaudhary H; Dhuna V; Singh J; Kamboj SS; Seshadri S
J Ethnopharmacol; 2011 Jun; 136(2):363-7. PubMed ID: 21575697
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of Eclipta alba extract as anticancer and multidrug resistance reversal agent.
Chaudhary H; Jena PK; Seshadri S
Nutr Cancer; 2014; 66(5):904-13. PubMed ID: 24896195
[TBL] [Abstract][Full Text] [Related]
4. Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells.
Sun BT; Zheng LH; Bao YL; Yu CL; Wu Y; Meng XY; Li YX
Eur J Pharmacol; 2011 Mar; 654(2):129-34. PubMed ID: 21195709
[TBL] [Abstract][Full Text] [Related]
5. Icaritin reverses multidrug resistance of HepG2/ADR human hepatoma cells via downregulation of MDR1 and P‑glycoprotein expression.
Sun L; Chen W; Qu L; Wu J; Si J
Mol Med Rep; 2013 Dec; 8(6):1883-7. PubMed ID: 24145579
[TBL] [Abstract][Full Text] [Related]
6. siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma.
Yang H; Ding R; Tong Z; Huang J; Shen L; Sun YU; Liao J; Yang Z; Hoffman RM; Wang C; Meng X
Anticancer Res; 2016 Jun; 36(6):2675-82. PubMed ID: 27272776
[TBL] [Abstract][Full Text] [Related]
7. Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein.
Xiang QF; Zhang DM; Wang JN; Zhang HW; Zheng ZY; Yu DC; Li YJ; Xu J; Chen YJ; Shang CZ
Liver Int; 2015 Mar; 35(3):1010-23. PubMed ID: 24621440
[TBL] [Abstract][Full Text] [Related]
8. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
9. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
10. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II.
Huang C; Xu D; Xia Q; Wang P; Rong C; Su Y
J Pharm Pharmacol; 2012 Dec; 64(12):1741-50. PubMed ID: 23146037
[TBL] [Abstract][Full Text] [Related]
11. Steroidal saponin of Trillium tschonoskii. Reverses multidrug resistance of hepatocellular carcinoma.
Wang H; Zhai Z; Li N; Jin H; Chen J; Yuan S; Wang L; Zhang J; Li Y; Yun J; Fan J; Yi J; Ling R
Phytomedicine; 2013 Aug; 20(11):985-91. PubMed ID: 23786867
[TBL] [Abstract][Full Text] [Related]
12. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
Tsang WP; Kwok TT
Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456
[TBL] [Abstract][Full Text] [Related]
13. Reversal of P-glycoprotein-mediated multidrug resistance in human hepatoma cells by hedyotiscone A, a compound isolated from Hedyotis corymbosa.
Yue GG; Kin-Ming Lee J; Cheng L; Chung-Lap Chan B; Jiang L; Fung KP; Leung PC; Bik-San Lau C
Xenobiotica; 2012 Jun; 42(6):562-70. PubMed ID: 22352391
[TBL] [Abstract][Full Text] [Related]
14. Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression.
Zheng LH; Bao YL; Wu Y; Yu CL; Meng X; Li YX
Cancer Lett; 2008 Dec; 272(1):102-9. PubMed ID: 18703276
[TBL] [Abstract][Full Text] [Related]
15. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line.
Nishanth RP; Ramakrishna BS; Jyotsna RG; Roy KR; Reddy GV; Reddy PK; Reddanna P
Eur J Pharmacol; 2010 Dec; 649(1-3):74-83. PubMed ID: 20858479
[TBL] [Abstract][Full Text] [Related]
16. [Intercellular transfer of P-glycoprotein in hepatocellular cell line HepG2].
Chen L; Zuo GQ; Wu JF; Zeng GL; Li T; Liu ZJ; Tang KF
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):839-42. PubMed ID: 19958644
[TBL] [Abstract][Full Text] [Related]
17. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
Ding L; Chen XP; Zhang ZW; Jing K; Zhang WG
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036
[TBL] [Abstract][Full Text] [Related]
18. Reversal effect of Tween-20 on multidrug resistance in tumor cells in vitro.
Yang S; Liu J; Chen Y; Jiang J
Biomed Pharmacother; 2012 Apr; 66(3):187-94. PubMed ID: 22440896
[TBL] [Abstract][Full Text] [Related]
19. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
[TBL] [Abstract][Full Text] [Related]
20. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
Lu F; Hou YQ; Song Y; Yuan ZJ
Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
